173 related articles for article (PubMed ID: 16945832)
1. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.
Tokarska-Schlattner M; Wallimann T; Schlattner U
C R Biol; 2006 Sep; 329(9):657-68. PubMed ID: 16945832
[TBL] [Abstract][Full Text] [Related]
2. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.
Tokarska-Schlattner M; Zaugg M; Zuppinger C; Wallimann T; Schlattner U
J Mol Cell Cardiol; 2006 Sep; 41(3):389-405. PubMed ID: 16879835
[TBL] [Abstract][Full Text] [Related]
3. Diabetic cardiomyopathy.
Feuvray D
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):261-5. PubMed ID: 15106750
[TBL] [Abstract][Full Text] [Related]
4. Alterations in energy metabolism in cardiomyopathies.
Taha M; Lopaschuk GD
Ann Med; 2007; 39(8):594-607. PubMed ID: 17934906
[TBL] [Abstract][Full Text] [Related]
5. Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply.
Tokarska-Schlattner M; Zaugg M; da Silva R; Lucchinetti E; Schaub MC; Wallimann T; Schlattner U
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H37-47. PubMed ID: 15764680
[TBL] [Abstract][Full Text] [Related]
6. [Functional changes in the mitochondrial site of adenylate kinase and creatine kinase systems of energy transport induced by myocardial ischemia and adriablastin].
Toleĭkis AI; Kal'venas AA; Dzheia PP; Prashkiavichius AK; Iasaĭtis AA
Biokhimiia; 1988 Apr; 53(4):649-54. PubMed ID: 2840129
[TBL] [Abstract][Full Text] [Related]
7. Effects of mitoxantrone and doxorubicin on energy metabolism of the rat heart.
Bachmann E; Weber E; Zbinden G
Cancer Treat Rep; 1987 Apr; 71(4):361-6. PubMed ID: 3829012
[TBL] [Abstract][Full Text] [Related]
8. Insulin signalling in the heart.
Bertrand L; Horman S; Beauloye C; Vanoverschelde JL
Cardiovasc Res; 2008 Jul; 79(2):238-48. PubMed ID: 18390897
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity of copper-based antineoplastic drugs casiopeinas is related to inhibition of energy metabolism.
Hernández-Esquivel L; Marín-Hernández A; Pavón N; Carvajal K; Moreno-Sánchez R
Toxicol Appl Pharmacol; 2006 Apr; 212(1):79-88. PubMed ID: 16051288
[TBL] [Abstract][Full Text] [Related]
10. The failing heart--an engine out of fuel.
Neubauer S
N Engl J Med; 2007 Mar; 356(11):1140-51. PubMed ID: 17360992
[No Abstract] [Full Text] [Related]
11. The C60-fullerene porphyrin adducts for prevention of the doxorubicin-induced acute cardiotoxicity in rat myocardial cells.
Shetab Boushehri SV; Ostad SN; Sarkar S; Kuznetsov DA; Buchachenko AL; Orlova MA; Minaii B; Kebriaeezadeh A; Rezayat SM
Acta Med Iran; 2010; 48(5):342-50. PubMed ID: 21287470
[TBL] [Abstract][Full Text] [Related]
12. Metabolic remodelling of the failing heart: beneficial or detrimental?
van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity.
Mitra MS; Donthamsetty S; White B; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2007 Nov; 225(1):90-101. PubMed ID: 17904602
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
Conklin KA
Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
[TBL] [Abstract][Full Text] [Related]
15. Energy metabolism in heart failure and remodelling.
Ingwall JS
Cardiovasc Res; 2009 Feb; 81(3):412-9. PubMed ID: 18987051
[TBL] [Abstract][Full Text] [Related]
16. Chronic corticosterone injections induce a decrease of ATP levels and sustained activation of AMP-activated protein kinase in hippocampal tissues of male mice.
Zhao Y; Shen J; Su H; Li B; Xing D; Du L
Brain Res; 2008 Jan; 1191():148-56. PubMed ID: 18164281
[TBL] [Abstract][Full Text] [Related]
17. AMPK signalling and the control of substrate use in the heart.
Nagendran J; Waller TJ; Dyck JR
Mol Cell Endocrinol; 2013 Feb; 366(2):180-93. PubMed ID: 22750050
[TBL] [Abstract][Full Text] [Related]
18. The AMP-activated protein kinase: more than an energy sensor.
Hue L; Rider MH
Essays Biochem; 2007; 43():121-37. PubMed ID: 17705797
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
Jiang W; Zhu Z; Thompson HJ
Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
[TBL] [Abstract][Full Text] [Related]
20. [Myocardium metabolism].
Hassinen I
Duodecim; 1985; 101(21):2029-37. PubMed ID: 4076003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
